CN105001338B - A kind of diazepam lipocalin analog antibodies - Google Patents

A kind of diazepam lipocalin analog antibodies Download PDF

Info

Publication number
CN105001338B
CN105001338B CN201410157737.4A CN201410157737A CN105001338B CN 105001338 B CN105001338 B CN 105001338B CN 201410157737 A CN201410157737 A CN 201410157737A CN 105001338 B CN105001338 B CN 105001338B
Authority
CN
China
Prior art keywords
lipocalin
diazepam
antibody
analog
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410157737.4A
Other languages
Chinese (zh)
Other versions
CN105001338A (en
Inventor
宁保安
高志贤
孙思明
彭媛
白家磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Hygiene and Environmental Medicine Academy of Military Medical Sciences of Chinese PLA
Original Assignee
Institute of Hygiene and Environmental Medicine Academy of Military Medical Sciences of Chinese PLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Hygiene and Environmental Medicine Academy of Military Medical Sciences of Chinese PLA filed Critical Institute of Hygiene and Environmental Medicine Academy of Military Medical Sciences of Chinese PLA
Priority to CN201410157737.4A priority Critical patent/CN105001338B/en
Publication of CN105001338A publication Critical patent/CN105001338A/en
Application granted granted Critical
Publication of CN105001338B publication Critical patent/CN105001338B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a kind of diazepam lipocalin analog antibodies, the DNA sequence dna for expressing the antibody is the sequence in sequence table shown in SEQ ID NO.1.The diazepam lipocalin analog antibodies of the present invention lay a good foundation quickly detecting for diazepam to realize.In lipocalin, embedding rate of the recognition site in albumen that can be interacted with target molecules is up to 95%, and embedding rate of the binding site in antibody molecule is only 66%.This is because there is the big face that contacts with each other that can be combined with target molecules in lipocalin intramoleculars(Ingo,2003).Lipocalin is simple in structure, and molecular weight is small, have it is larger can stablize with the recognition site and skeleton that target molecules are combined, have unique advantage compared with antibody.

Description

A kind of diazepam lipocalin analog antibodies
Technical field
The present invention relates to a kind of diazepam analog antibody.Belong to biological technical field, which can be used for developing The quick detection remaining immunity detection reagent of diazepam.
Background technology
Diazepam(Diazepam, DZP), alias stabilizes or benzodiazepine, and chloro- 1, the 3- dihydros -1- methyl of chemical name 7- - 5- phenyl -2H-1,4- Benzodiazepine -2- ketone, molecular formula C16H13ClN2O, molecular weight 284.76.It belongs to long-acting Benzodiazepine Class anxiolytic, has antianxiety, calmness, hypnosis, anticonvulsion, anti-epileptic, relaxation skeletal muscle and eliminates the effect such as memory.Extensively Applied to clinical medicine, long-term use has additive and dependence.Diazepam is national contraband, is only used as prescription medicine and sells, With calm, syngignoscism, offender often implements crime using this feature of DZP, causes very great society harm.And throw Poison, wrongly take a large amount of DZP and poisoning also happens occasionally.Therefore, it is that strike is such to establish quick, sensitive DZP detection methods Criminal activity, a kind of important means of control DZP abuses.
The detection method of DZP focuses mostly in clinical medicine, criminal investigation context of detection, in blood, urine, stomach Dissolve things inside, liver The detection of diazepam.Common detection method has:Instrumental method, including high performance liquid chromatography(HPLC), thin layer chromatography scanning (TLC), Photochemical Fluorimetry(PCFA), differential spectrophotometry.Every kind of detection method also has the shortcoming of oneself.Greatly Type instrument detection method sensitivity is higher, can solve part practical problem.But its sample pre-treatments is cumbersome, expensive equipment, inspection Survey it is of high cost, need professional technician to operate, and during operating cost, analysis efficiency is low, and technology popularization is difficult, and most of is used for method To the identification of poisoning symptom on doctor, be not suitable for the remaining detection of diazepam in edible animal tissue, be not also suitable for live quick A large amount of detections.
Ribosomal display technology(Ribosome display, RD)It is a kind of simple and effective novel in vitro screening and molecule The biological libraries technology of evolution function protein, it is by amplifiable genomic information DNA or RNA and selectable protein Link together.MRNA lacks terminator codon and by appropriate modification in RD technologies, and ribose is known from experience in translation process in vitro The 3' ends of mRNA are rested on, mRNA is not disintegrated down with translation product from ribosomes, forms sufficiently stable " mRNA- Ribosomes-protein " ternary complex, this ternary complex form connect together protein with mRNA information, application RD can carry out peptide and the protein screening of specific function.Lipocalin is from unicellular lower eukaryote(Bacterium)To high mammal The general name of the one group of extracellular lipophilic protein all contained, is to be widely present in nature small protein family vdiverse in function, From unicellular lower eukaryote(Bacterium)To high mammal(Including the mankind)Find its trace.Lipocalin is from bilitrien Associated proteins(BBP)Middle discovery, it is present in large white butterfly(Pieris brassicaed)In, its openend be it is wide and Shallow β-barrel structure, is easier to combine with small-molecule substance.The Lipocalin libraries reported at present are all with bilitrien knot Hop protein comes for the support reformation.Although lipocalin protein plays different physiologic functions in different biologies, Transport and storage material with low solubility or chemosensitivity material, such as fragrant element, vitamin, steroids, a variety of two levels Metabolite and pheromones are their most typical biological functions.Due to lipocalin protein family higher structure feature with Antibody is similar, and lipocalin protein is but also with the unexistent advantage of some antibody, therefore, using Lipocalin as framework construction Mutated library be more and more widely used.Lipocalin mutant by design simulation has similar antibody Binding specificity, therefore analog antibody can be become.At present, using ribosomal display technology screening small molecular antibody research also Fewer, the screening for diazepam analog antibody has not been reported.
The content of the invention
The purpose of the present invention is obtain a kind of diazepam lipocalin analog antibodies.
Technical scheme is summarized as follows:
A kind of diazepam lipocalin analog antibodies, the DNA sequence dna for expressing the antibody are SEQ ID in sequence table Sequence shown in NO.1.
Advantages of the present invention:
, by taking turns biological screening, the diazepam lipocalin simulations obtained for diazepam high specific resist more for we Body.To realize that the quick detection to diazepam is laid a good foundation., can be with the knowledge of target molecules interaction in lipocalin Embedding rate of the other site in albumen is up to 95%, and embedding rate of the binding site in antibody molecule is only 66%.This is because There is the big face that contacts with each other that can be combined with target molecules in lipocalin intramoleculars(Ingo,2003).Lipocalin is tied Structure is simple, and molecular weight is small, have it is larger can stablize with the recognition site and skeleton that target molecules are combined, the tool with antibody compared with There is unique advantage.(Flower DR,1996).
Brief description of the drawings
Fig. 1 is the amplifiable property identification in the ribosomal display analog antibody library of structure.
Fig. 2 is for the qualification figure after the wheel screening of target small molecule diazepam five in analog antibody library.
Fig. 3 identifies for diazepam analog antibody positive colony daughter colony PCR.
Fig. 4 is the identification of diazepam analog antibody positive clone molecule.
Fig. 5 is the expression and purifying of diazepam analog antibody.
Fig. 6 is the competition binding activity that indirect competitive ELISA detects antibody.
Embodiment
Diazepam lipocalin analog antibodies provided by the invention are from ribosomal display Lipocalin analog antibodies storehouse It is that middle screening obtains and carried out soluble functional expression.
Embodiment 1
The amplifiable property identification in lipocalin analog antibodies library:
With a member of lipocalin families, bilitrien associated proteins(BBP)For skeleton, 16 mutation positions are randomly incorporated into Point, builds lipocalin ribosomal-display libraries.Using the lipocalin libraries of structure as template, using T7F and PDR as upstream and downstream Primer carries out PCR amplification, and purpose band is about 900bp.
T7 fragments such as Fig. 1 is expanded from pET32a plasmids by upstream and downstream primer T7F and RT7(A)It is shown, with primer PDF With the T20-V109 sequences in the glutelin D of PDR amplification Lambda bacteriophages as intervening sequence (i.e. P fragments), such as Fig. 1(B) It is shown.As can be seen from the figure there is purpose band at 102bp and 300bp, with T7 fragments and the size of P protein gene fragments It is consistent, illustrates to expand successfully.By sense primer FBBP and anti-sense primer Rtail, the BBP antibody libraries built are expanded Increase, agarose gel electrophoresis is identified shown in its result such as Fig. 1 (C), there is bright band at 558bp sizes, this is with building mould The size in lectin library is suitable.Thus, the amplifiable property in the ribosomal display analog antibody library of structure is good.
Primer sequence:T7F:5’-ATACGAAATTAATACGACTCAC-3’(SEQ ID NO.2)
PDR:5’-CCGCACACCAGTAAGGTGTGCGGTAACGATGCTGATTGCCGTTCCG-3’(SEQ ID NO.3)
RT7:5’-CATGGATATATCTCCTTCTTAAAG-3’(SEQ ID NO.4)
PDF:5’-GGTGGAGGTGGCTCTGGCGGTGGCGGATCTA-3’(SEQ ID NO.5)
FBBP:5’-GAAGGAGATATATCCATGAACGTGTACCACGACGGTGC-3’(SEQ ID NO.6)
Rtail:5’-CGCCAGAGCCACCTCCACCTGAACCGCCTCCACCATTGTTGACTTTGCAGGCG-3’(SEQ ID NO.7)
Embodiment 2
The screening of diazepam lipocalin analog antibodies
1 in-vitro transcription and translation
E.coli S30 of the in-vitro transcription with translation using Promega(Escherichia coli S30Extract System)Linear die system, it will be transcribed together with translation coupling.
2 solid-phase screenings
(1) it is coated with:ELISA Plate takes the comlete antigen DZP-OVA/DZP-BSA after coupling, uses after the immersion drying of DEPC water Carbonate buffer solution is diluted to 10 μ g/mL, and per 200 μ L are added in hole, 8h is incubated under the conditions of 4 DEG C.
(2) second days, coating buffer of inclining, washed coating hole 3 times, each 3min with the PBS after sterilizing;Then hole will be coated with In plus 200 μ L confining liquid(0.5% BSA or 1%OVA), close 1h.The liquid of falling deblocking, PBS are eluted 2 times, each 2min, The WBT of precooling is used again(150mmol/L NaCl, 50mmol/L Tris-acetate pH7.5,0.1%Tween, 50mmol/L magnesium acetate)Washing 2 times, each 2min, WBT is then filled in screen holes, places 20min on ice.Experiment is adopted The mode for taking secondary screening to select, adds one during closing and does not contain envelope antigen, containing only the screen holes of carrier protein BSA or OVA.
(3) product after the translation placed on ice is gone to be ready for contain only carrier protein(BSA or OVA)Screening Kong Zhong, when shaking 1 is small under the conditions of 4 DEG C.After translation product is fully combined with carrier protein, then the liquid in hole is added to 1h is shaked in screen holes containing coating antigen, to reduce non-specific binding.
(4) liquid being incubated in screen holes of inclining, is washed 3 times, each 2min with the WBT solution of precooling.
(5) liquid in screen holes of inclining, adds the elution buffer of the prior precooling of 100 μ l in screen holes, then The RNase inhibitor of 1 μ L is added, 4 DEG C of shaking 10min, make the big small subunit separation of ribosomes, discharge mRNA.Eluent is drawn, so The Dnase I of 1 μ l is added afterwards, 15min is incubated under the conditions of 37 DEG C, removes DNA profiling unnecessary in reaction system.
(6) 5 steps are repeated.
(7) obtained mRNA is purified immediately.
(8) RT-PCR of mRNA
3. rebuild the ribosomal display template of next round
BBP library fragments after recycling and T7 promoters and P fragments are built into library using the method for SOE-PCR.
(1)The amplification of T fragments
(2)The amplification of P fragments
(3)T7 promoters and the connection in BBP analog antibodies library:
(4)The connection of T7+BBP fragments and P fragments:
Embodiment 3
Identification after the wheel screening of diazepam lipocalin analog antibodies five
Plasmid pMD18-T-BBP will be extracted after right-on strain culturing is sequenced, double digestion is then carried out, after digestion The BBP fragments containing restriction enzyme site are obtained, endonuclease reaction system is the same.
Fig. 2 show it is every wheel screening after, there is EDTA to disintegrate down mRNA from triplet compound, using PM as primer into Row reversion, obtains cDNA, then, then using FBBP and Rtail as primer amplification analog antibody fragment.Through 1.5% Ago-Gel Electroresis appraisal, can see purposeful band in size about at 500bp.After being connected after being recycled with ribosomal display element The library screened to the next round of 900bp.Fig. 2 is after being screened from analog antibody library for the wheel of target small molecule diazepam five Qualification figure, as shown in Figure 2, the mRNA amounts of the acquisition after first round screening are less, obtained band after progress RT-PCR reversions It is very weak.But with the increase of screening number, the band of RT-PCR products is increasingly brighter, after five wheel screenings, due to pin Enrichment is obtained for the analog antibody gene of small molecule diazepam, the analog antibody gene to be become clear after RT-PCR.This Prove by the external affine screening of ribosomal display technology, the specific analog antibody gene being combined can be carried out with diazepam Obvious enrichment is obtained.
PM:5’-GCAAGAATGCCAACGGCAGC-3’(SEQ ID NO.8)
Embodiment 4
The sequencing of RT-PCR products after the wheel screening of diazepam lipocalin analog antibodies five
Reversion primer of the amplified production containing restriction enzyme digestion sites that will be obtained after five wheel screenings EXPRESS and REPRESS amplifications, introduce restriction enzyme site at gene order both ends, are connected to after adding A on cloning vector pMD18-T, Then it is transformed into E.coil.Fig. 3 is diazepam-analog antibody positive colony daughter colony PCR identifications.Single positive gram is selected at random Send the sequencing identification of Invitrogen companies in Longzi.
EXPRESS(Introduce EcoRI restriction enzyme sites):5′-CGCGAA TTC TAA ATG AAC GTG TAC CAC GAC GGTG-3′(SEQ ID NO.9)
REPRESS(Introduce XhoI restriction enzyme sites):5′-GCCCTC GAG ATT GTT GAC TTT GCA GGC GGCG-3′(SEQ ID NO.10)
Embodiment 5
The identification of diazepam lipocalin analog antibody positive clone molecules and protein purification
In the screening to target molecules diazepam, still with bilitrien associated proteins(BBP)For the screening of framework construction Screened in storehouse.Clone of the picking containing pTIG-TRX-BBP is incubated overnight, and EcoR I and XhoI restriction endonucleases are used after extracting plasmid Double digestion processing is carried out to clone, product is identified with agarose gel electrophoresis after digestion.Digestion result such as Fig. 4 shows, digestion The fragment of size about 500bp is obtained afterwards, it is and expected consistent.The dientification of bacteria the result shows that, diazepam-analog antibody gene is correctly inserted Enter into expression pTIG-TRX.The clone strain for being accredited as the positive is induced with IPTG, 30 DEG C of induced expression 4h, bacterium solution centrifugation After taking precipitation to be resuspended, SDS-PAGE electrophoresis detections are carried out.Protein molecular is understood according to gene order and the analysis of the size of amino acid Measure as 20Kda or so.Due to being connected with label A nti-His tag on analog antibody, thus use the affine layers of Anti-His tag Analysis column purifies single-chain antibody.Albumen is sequestered on chromatographic column by 6 × His labels and Ni2+ interactions, then is passed through Elution containing imidazoles.Purification result is shown in Fig. 5 (B), as can be seen from the figure elute after purpose band go out to have one it is bright Band, and the concentration of foreign protein is decreased obviously.Illustrate that albumen is purified.Albumen after purification carries out SDS-PAGE electricity After swimming, such as Fig. 5(C)It is shown, further illustrate Protein expression and purification success, albumen exists in the form of soluble.
Embodiment 6
The Property Identification of diazepam lipocalin analog antibodies
The gene order that screening obtains, which is imported into expression vector, to be expressed, and albumen size is 20KDa.1 is cloudy in Fig. 5 Property(Empty plasmid bacterial strain is expressed)2,3 be the supernatant after broken containing the purpose bacterial strain expression screened, wherein 2 be that size is 470bp Gene order imported into the albumen expressed in expression vector, 3 be the albumen that the gene order that size is 520bp is expressed.But Size is that the albumen after the gene expression of 470bp is active without competition.4 be the strain protein expression and purification that gene is 520bp Rear electrophoresis, 5,6 be albumen progress Western Blot identifications after purification.As can be seen from Figure 5 containing the purpose base screened The expression system energy successful expression albumen of cause, and can successful purification.The diazepam lipocalin simulations obtained by sequencing are anti- The DNA sequence dna of body is the sequence shown in SEQ ID NO.1 in sequence table.Its competition activity is analyzed preferably by competitive ELISA, such as Fig. 6 is with the increase of the concentration of small molecule, and inhibiting rate is bigger, and small molecule is stronger to the competitiveness of envelope antigen.Detection range is: 0.04-17.70 μ g/mL, sensitivity are 0.41 μ g/mL.The diazepam lipocalin analog antibodies that we screen acquisition can be used The remaining immunity detection reagent of diazepam is quickly detected in developing.

Claims (1)

  1. A kind of 1. diazepam lipocalin analog antibodies, it is characterized in that the DNA sequence dna for expressing the antibody is SEQ in sequence table Sequence shown in ID NO.1.
CN201410157737.4A 2014-04-18 2014-04-18 A kind of diazepam lipocalin analog antibodies Expired - Fee Related CN105001338B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410157737.4A CN105001338B (en) 2014-04-18 2014-04-18 A kind of diazepam lipocalin analog antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410157737.4A CN105001338B (en) 2014-04-18 2014-04-18 A kind of diazepam lipocalin analog antibodies

Publications (2)

Publication Number Publication Date
CN105001338A CN105001338A (en) 2015-10-28
CN105001338B true CN105001338B (en) 2018-05-01

Family

ID=54374227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410157737.4A Expired - Fee Related CN105001338B (en) 2014-04-18 2014-04-18 A kind of diazepam lipocalin analog antibodies

Country Status (1)

Country Link
CN (1) CN105001338B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172740A (en) * 2011-12-26 2013-06-26 中国人民解放军军事医学科学院卫生学环境医学研究所 Preparation method of beta-estradiol analogue antibody and use thereof
CN103172694A (en) * 2011-12-26 2013-06-26 中国人民解放军军事医学科学院卫生学环境医学研究所 Screening method of ampicillin special conjugate and use of conjugate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172740A (en) * 2011-12-26 2013-06-26 中国人民解放军军事医学科学院卫生学环境医学研究所 Preparation method of beta-estradiol analogue antibody and use thereof
CN103172694A (en) * 2011-12-26 2013-06-26 中国人民解放军军事医学科学院卫生学环境医学研究所 Screening method of ampicillin special conjugate and use of conjugate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Construction of ribosome display library based on lipocalin scaffold and screening anticalins with specificity for estradiol;Jianqing Liu等;《Analyst》;20121231;第137卷(第10期);第2470-2479页 *
基于脂运载蛋白骨架的抗体库构建与农兽药残留抗体的筛选;宁保安,等;《中国药理学与毒理学杂志》;20131130;第27卷;摘要 *

Also Published As

Publication number Publication date
CN105001338A (en) 2015-10-28

Similar Documents

Publication Publication Date Title
Amraee et al. DNA aptamer identification and characterization for E. coli O157 detection using cell based SELEX method
Broussard et al. Integration-dependent bacteriophage immunity provides insights into the evolution of genetic switches
EP0610448B1 (en) Peptide library and screening method
Kal et al. Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources
US5733731A (en) Peptide library and screening method
Cowie et al. An integrated approach to functional genomics: construction of a novel reporter gene fusion library for Sinorhizobium meliloti
Lam et al. Global analysis of the HrpL regulon in the plant pathogen Pseudomonas syringae pv. tomato DC3000 reveals new regulon members with diverse functions
Ortega et al. Non-coding RNA regulation in pathogenic bacteria located inside eukaryotic cells
JP2002520074A (en) Cis-acting nucleic acid elements and methods of use
CN107254518A (en) The quantitative detecting method of enteric bacteria antibiotics resistance gene
JP2002527098A (en) Methods and reagents for isolating biologically active peptides
CN104561008A (en) Homocysteine aptamer HCy1 and preparation method thereof
CN107091929B (en) A kind of promoter batch catching method
Zhu et al. Type VI secretion system is not required for virulence on rice but for inter-bacterial competition in Xanthomonas oryzae pv. oryzicola
CN110229846B (en) Universal positive standard plasmid for screening transgenic rice and construction method thereof
Han et al. A small regulatory RNA contributes to the preferential colonization of Escherichia coli O157: H7 in the large intestine in response to a low DNA concentration
CN105001338B (en) A kind of diazepam lipocalin analog antibodies
CN108559715A (en) The yeast transformant and its screening technique of screening and G-protein β γ dimer interacting proteins
Ahn et al. Ptr1 and ZAR1 immune receptors confer overlapping and distinct bacterial pathogen effector specificities
JP2022500032A (en) Transcription recording by acquisition of CRISPR spacer from RNA
CN106591315A (en) Aptamer C202 of staphylococcus aureus enterotoxin C2 as well as screening method and applications thereof
CN103045602B (en) DNA aptamer capable of specifically binding tetrodotoxin and application of DNA aptamer
CN104561010B (en) Homocysteine aptamer HCy5 and preparation method thereof
CN103172740A (en) Preparation method of beta-estradiol analogue antibody and use thereof
CN108486119B (en) Aptamer RhB-F02 specifically bound with rhodamine B and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180501

Termination date: 20190418